Exelgyn

Exelgyn is a French pharmaceutical company which makes and distributes the medical abortion drugs mifepristone (marketed as Mifegyne) and misoprostol.

History
Mifepristone was originally developed by the French pharmaceutical company Roussel-Uclaf. In 1997, after buying the remaining 43.5% of Roussel-Uclaf stock in early 1997, Hoechst AG announced the end of its manufacture and sale of Mifegyne  and the transfer of all rights for medical uses of mifepristone outside of the United States to Exelgyn S.A., a new single-product company immune to antiabortion boycotts, whose CEO was former Roussel-Uclaf CEO Édouard Sakiz.

In 1999, Exelgyn won approval of Mifegyne in 11 additional countries. As of 2024, Exelgyn distributes mifepristone to 40 countries, but within the United States it is distributed by Danco Laboratories.